The major histocompatibility complex-encoded HFE in iron homeostasis and immune function

Immunologic Research

Volumn 22, Issue 1, 2000, Pages 43-59

  Salter Cid, Luisa ^a   Peterson, Per A ^a   Yang, Young ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Class I MHC antigen; Hemochromatosis; Immune function; Iron transporters; Transferrin receptor

Indexed keywords

BETA 2 MICROGLOBULIN; CYTOKINE; IRON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TRANSFERRIN RECEPTOR;

HOMEOSTASIS; HUMAN; IMMUNITY; INTERNALIZATION; IRON METABOLISM; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 0033927268     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/ir:22:1:43     Document Type: Review

References (132)

1. 1. Santos M, Schilham MW, Rademakers LH, Marx JJ, de Sousa M, Clevers H: Defective iron homeostasis in β2-microglobulin knockout mice recapitulates hereditary hemochromatosis in man. J Exp Med 1996;184:1975-1985.
2. 2. Rothenberg BE, Voland JR: β-2 knockout mice develop parenchymal iron overload: A putative role for class I genes of the major histocompatibility complex in iron metabolism. Proc Natl Acad Sci USA 1996;93:1529-1534.
3. 3. Bothwell TH, Charlton RW, Motulski AG: Hemochromatosis, in The Metabolic and Molecular Bases of Inherited Disease. Scriver CR, Beaudet AL, Sly WS, Valle D, eds. McGraw-Hill, New York. 1995, pp. 2237-2269.
4. 4. Jazwinska EC: Hemochromatosis: a genetic defect in iron metabolism. Bioessays 1998;20:562-568.
5. 5. Simon M, Brissot P: The genetics of hemochromatosis. J Hepatol 1988;6:116-124.
6. 6. Simon M, Bourel M, Fauchet R, Genetet B: Association of HLA-A3 and HLA-B14 antigens with idiopathic hemochromatosis. Gut 1976;17:332-334.
7. 7. Jazwinska EC, Lee SC, Webb SI, Halliday JW, Powell LW: Localization of the hemochromatosis gene close to D6S105. Am J Hum Genet 1993;53:347-352.
8. 8. Gasparini P, Borgato L, Piperno A, et al.: Linkage analysis of 6p21 polymorphic markers and the hereditary hemochromatosis: localization of the gene centromeric to HLA-F. Hum Mol Genet 1993;2:571-576.
9. 9. Jazwinska EC, Pyper WR, Burt MJ, et al.: Haplotype analysis in Australian hemochromatosis patients: evidence for a predominant ancestral haplotype exclusively associated with hemochromatosis. Am J Hum Genet 1995;56:428-433.
10. 10. Raha-Chowdhury R, Bowen DJ, Stone C, et al.: New polymorphic microsatellite markers place the hemochromatosis gene telomeric to D6S105. Hum Mol Genet 1995; 4:1869-1874.
11. 11. Feder JN, Gnirke A, Thomas W, et al.: A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis. Nat Genet 1996;13:399-408.
12. 12. Beutler E, Gelbart T: HLA-H mutations in the Ashkenazi Jewish population. Blood Cells Mol Dis 1997;23:95-98.
13. 13. Cuthbert JA: Iron, HFE, and hemochromatosis update. J Invest Med 1997;45:518-529.
14. 14. Gerhard GS, Ten Elshof AE, Chorney MJ: Hereditary hemochromatosis as an immunological disease. Br J Haematol 1998; 100:247-255.
15. 15. Chang JG, Liu TC, Lin SF: Rapid diagnosis of the HLA-H gene Cys 282 Tyr mutation in hemochromatosis by polymerase chain reaction - a very rare mutation in the Chinese population. Blood 1997; 89:3492-3493.
16. 16. Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ: Global prevalence of putative hemochromatosis mutations. J Med Genet 1997;34:275-278.
17. 17. Roth M, Giraldo P, Hariti G, et al.: Absence of the hemochromatosis gene Cys282Tyr mutation in three ethnic groups from Algeria (Mzab), Ethiopia, and Senegal. Immunogenetics 1997;46:222-225.
18. 18. Zhou XY, Tomatsu S, Fleming RE, et al.: HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci USA 1998;95:2492-2497.
19. 19. Bahram S, Gilfillan S, Kühn LC, Moret R, Schulze JB, Lebeace A, Schümann K: Experimental hemochromatosis due to MHC class I HFE deficiency: Immune status and iron metabolism. Proc Natl Acad Sci USA 1999;96:13312-13317.
20. 20. Shawar SM, Vyas JM, Rodgers JR, Rich RR: Antigen presentation by major histocompatibility complex class I-b molecules. Annu Rev Immunol 1994;12:839-880.
21. 21. Braud VM, Allan DS, McMichael AJ: Functions of nonclassical MHC and non-MHC-encoded class I molecules. Curr Opin Immunol 1999; 11:100-108.
22. 22. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC: The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 1987;329:512-518.
23. 23. Bjorkman PJ, Parham P: Structure, function, and diversity of class I major histocompatibility complex molecules. Annu Rev Biochem 1990;59:253-288.
24. 24. Lawlor DA, Zemmour J, Ennis PD, Parham P: Evolution of class-I MHC genes and proteins: from natural selection to thymic selection. Annu Rev Immunol 1990;8:23-63.
25. 25. Rammensee HG, Falk K, Rotzschke O: MHC molecules as peptide receptors. Curr Opin Immunol 1993;5:35-44.
26. 26. Bevan MJ: High determinant density may explain the phenomenon of alloreactivity. Immunology Today 1984;5:128-138.
27. 27. Vidovic D, Matzinger P: Unresponsiveness to a foreign antigen can be caused by self-tolerance. Nature 1988;336:222-225.
28. 28. Fourie AM, Yang Y: Molecular requirements for assembly and intracellular transport of class I major histocompatibility complex molecules. Curr Top Microbiol Immunol 1998;232:49-74.
29. 29. Yang Y, Sempe P, Peterson PA: Molecular mechanisms of class I major histocompatibility complex antigen processing and presentation. Immunol Res 1996;15:208-233.
30. 30. Saper MA, Bjorkman PJ, Wiley DC: Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. J Mol Biol 1991;219:277-319.
31. 31. Stroynowski I, Lindahl KF: Antigen presentation by nonclassical class I molecules. Curr Opin Immunol 1994;6:38-44.
32. 32. Stroynowski I, Forman J: Novel molecules related to MHC antigens. Curr Opin Immunol 1995; 7:97-102.
33. 33. Salter-Cid L, Flajnik MF: Evolution and developmental regulation of the major histocompatibility complex. Crit Rev Immunol 1995; 15:31-75.
34. 34. Braud VM, Allan DS, O'Callaghan CA, et al.: HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998;391:795-799.
35. 35. Borrego F, Ulbrecht M, Weiss EH, Coligan JE, Brooks AG: Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J Exp Med 1998;187:813-818.
36. 36. Lee N, Llano M, Carretero M, et al.: HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci USA 1998;95:5199-5204.
37. 37. Hashimoto K, Hirai M, Kurosawa Y: Identification of a mouse homolog for the human hereditary hemochromatosis candidate gene. Biochem Biophys Res Commun 1997;230: 35-39.
38. 38. Lebron JA, Bennett MJ, Vaughn DE, et al.: Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell 1998;93:111-123.
39. 39. Feder JN, Tsuchihashi Z, Irrinki A, et al.: The hemochromatosis founder mutation in HLA-H disrupts β2-microglobulin interaction and cell surface expression. J Biol Chem 1997;272:14025-14028.
40. 40. Waheed A, Parkkila S, Zhou XY, et al.: Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with β2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Proc Natl Acad Sci USA 1997; 94:12384-12389.
41. 41. Parkkila S, Waheed A, Britton RS, et al.: Immunohistochemistry of HLA-H, the protein defective in patients with hereditary hemochromatosis, reveals unique pattern of expression in gastrointestinal tract. Proc Natl Acad Sci USA 1997;94:2534-2539.
42. 42. Sanchez M, Queralt R, Bruguera M, Rodes J, Oliva R: Cloning, sequencing and characterization of the rat hereditary hemochromatosis promoter: Comparison of the human, mouse and rat HFE promoter regions. Gene 1998; 225:77-87.
43. 43. Akira S, Isshiki H, Sugita T, et al.: A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J 1990; 9:1897-1906.
44. 44. Fruh K, Yang Y: Antigen presentation by MHC class I and its regulation by interferon γ. Curr Opin Immunol 1999;11:76-81.
45. 45. Fruh K, Karlsson L, Yang Y: γ interferon in antigen processing and presentation. Gamma Interferon Antiviral Def 1997:39-59.
46. 46. Yang Z, Sugawara M, Ponath PD, et al.: Interferon γ response region in the promoter of the human DPA gene. Proc Natl Acad Sci USA 1990;87:9226-9230.
47. 47. David-Watine B, Israel A, Kourilsky P: The regulation and expression of MHC class I genes. Immunol Today 1990;11:286-292.
48. 48. Gustafson KS, Ginder GD: Interferon-γ induction of the human leukocyte antigen-E gene is mediated through binding of a complex containing STATl alpha to a distinct interferon-γ-responsive element. J Biol Chem 1996; 271:20,035-20,046.
49. 49. Salter-Cid L, Brunmark A, Li Y, et al.: Transferrin receptor is negatively modulated by the hemochromatosis protein HFE: Implications for cellular iron homeostasis. Proc Natl Acad Sci USA 1999;96:5434-5439.
50. 50. Parkkila S, Waheed A, Britton RS, et al.: Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci USA 1997;94:13,198-13,202.
51. 51. Feder JN, Penny DM, Irrinki A, et al.: The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci USA 1998;95:1472-1477.
52. 52. Schneider C, Owen MJ, Banville D, Williams JG: Primary Structure of Human Transferrin Receptor deduced from the mRNA Sequence. Nature 1984;311:675-679.
53. 53. Seligman PA, Schleicher RB, Allen RH: Isolation and characterization of the transferrin receptor from human placenta. J Biol Chem 1979; 254:9943-9946.
54. 54. Jing SQ, Trowbridge IS: Identification of the intermolecular disulfide bonds of the human transferrin receptor and its lipid-attachment site. EMBO J 1987;6:327-331.
55. 55. Harford JB, Rouault TA, Huebers HA, Klausner RD: Molecular Mechanisms of Iron Metabolism, in Molecular Basis of Blood Diseases. Stamatoyannopoulos G, Nienhhuis A, Majerus PM, Varmus H, eds. Saunders, Philadalphia. 1994, p. 351.
56. 56. Richardson DR, Ponka P: The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. Biochim Biophys Acta 1997; 1331:1-40.
57. 57. Lawrence CM, Ray S, Babyonyshev M, Galluser R, Borhani DW, Harrison SC: Crystal structure of the ectodomain of human transferrin receptor. Science 1999;286:779-782.
58. 58. Gross CN, Irrinki A, Feder JN, Enns CA: Co-trafficking of HFE, a nonclassical major histocompatibility complex class I protein, with the transferrin receptor implies a role in intracellular iron regulation. J Biol Chem 1998; 273:22,068-22,074.
59. 59. Aisen P, Wessling-Resnick M, Leibold EA: Iron metabolism. Curr Opin Chem Biol 1999;3:200-206.
60. 60. Hentze MW: Translational control by iron-responsive elements. Adv Exp Med Biol 1994;356:119-126.
61. 61. Eisenstein RS, Blemings KP: Iron regulatory proteins, iron responsive elements and iron homeostasis. J Nutr 1998;128:2295-2298.
62. 62. Lebron JA, West AP, Jr., Bjorkman PJ: The hemochromatosis protein HFE competes with transferrin for binding to the transferrin receptor. J Mol Biol 1999;294:239-245.
63. 63. Lebron JA, Bjorkman PJ: The transferrin receptor binding site on HFE, the class I MHC-related protein mutated in hereditary nemochromatosis. J Mol Biol 1999; 289:1109-1118.
64. 64. Salter-Cid L, Brunmarl A, Peterson P, Yang Y: The major histocompatibility complex-encoded class 1-like HFE abrogates endocytosis of transferin receptor by inducing receptor phosphorylation. Genes and Immunity 2000 (in pess).
65. 65. Roy CN, Penny DM, Feder JN, Enns CA: The hereditary hemochromatosis protein, HFE, specifically regulates transferrin-mediated iron uptake in HeLa cells. J Biol Chem 1999;274:9022-9028.
66. 66. Collawn JF, Stangel M, Kuhn LA, et al.: Transferrin receptor internalization sequence YXRF implicates a tight turn as the structural recognition motif for endocytosis. Cell 1990;63:1061-1072.
67. 67. Collawn JF, Lai A, Domingo D, Fitch M, Hatton S, Trowbridgel S: YTRF is the conserved internalization signal of the transferrin receptor, and a second YTRF signal at position 31-34 enhances endocytosis. J Biol Chem 1993; 268:21,686-21,692.
68. 68. Girones N, Alvarez E, Seth A, Lin IM, Latour DA, Davis RJ: Mutational analysis of the cytoplasmic tail of the human transferrin receptor. Identification of a sub-domain that is required for rapid endocytosis. J Biol Chem 1991;266:19,006-19,012.
69. 69. Johnstone RM, Adam M, Pan BT: The fate of the transfenrin receptor during maturation of sheep reticulocytes in vitro. Can J Biochem Cell Biol 1984;62:1246-1254.
70. 70. Johnstone RM, Adam M, Turbide C, Larrick J: Phosphorylation of the transferrin receptor in isolated sheep reticulocyte plasma membranes. Can J Biochem Cell Biol 1984;62:927-934.
71. 71. May WS, Sahyoun N, Jacobs S, Wolf M, Cuatrecasas P: Mechanism of phorbol diester-induced regulation of surface transferrin receptor involves the action of activated protein kinase C and an intact cytoskeleton. J Biol Chem 1985;260:9419-9426.
72. 72. Davis RJ, Johnson GL, Kelleher DJ, Anderson JK, Mole JE, Czech MP: Identification of serine 24 as the unique site on the transferrin receptor phosphorylated by protein kinase C. J Biol Chem 1986; 261:9034-9041.
73. 73. Castagnola J, MacLeod C, Sunada H, Mendelsohn J, Taetle R: Effects of epidermal growth factor on transferrin receptor phosphorylation and surface expression in malignant epithelial cells. J Cell Physiol 1987;132:492-500.
74. 74. Sugita M, Jackman RM, van Donselaar E, et al.: Cytoplasmic tail-dependent localization of CD1b antigen-presenting molecules to MIICs. Science 1996;273:349-352.
75. 75. Marks MS, Woodruff L, Ohno H, Bonifacino JS: Protein targeting by tyrosine-and di-leucine-based signals: Evidence for distinct saturable components. J Cell Biol 1996;135:341-354.
76. 76. Boll W, Ohno H, Songyang Z, et al.: Sequence requirements for the recognition of tyrosine-based endocytic signals by clathrin AP-2 complexes. EMBO J 1996;5:5789-5795.
77. 77. Mangasarian A, Piguet V, Wang J-K, Chen Y-L, Trono D: Nefinduced CD4 and major histocompatibility complex class I (MHC-I) down-regulation are governed by distinct determinants: N-terminal alpha helix and proline repeat of Nef selectively regulate MHC-I trafficking. J irol 1999;73:1964-1973.
78. 78. Greenberg ME, Iafrate AJ, Skowronski J: The SH3 domain-binding surface and an acidic motif in HTV-1 Nef regulate trafficking of class I MHC complexes. EMBO J 1998; 17:2777-2789.
79. 79. Greenberg M, De Tulleo L, Rapoport I, Skowronski J, Kirchhausen T: A dileucine motif in HIV-1 Nef is essential for sorting into clathrin-coated pits and for downregulation of CD4. Curr. Biol. 1998;8:1239-1242.
80. 80. Le Gall S, Benichou S, Erdtmann L, et al. Analysis of Nef-induced major histocompatibility complex class I modulation, Retroviruses Hum. AIDS Relat. Anim. Dis., Colloq. Cent Gardes, 11th, 1998. Elsevier, Paris, Fr.
81. 81. Kawabata H, Yang R, Hirama T, et al.: Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family. J Biol Chem 1999; 274:20,826-20,832.
82. 82. Huebers HA, Finch CA: The physiology of transferrin and transferrin receptors. Physiol Rev 1987; 67:520-582.
83. 83. Sayers MH, English G, Finch C: Capacity of the store-regulator in maintaining iron balance. Am J Hematol 1994;47:194-200.
84. 84. Wood RJ, Han O: Recently identified molecular aspects of intestinal iron absorption. J Nutr 1998; 128:1841-1844.
85. 85. Fleming MD, Trenor CC, 3rd, Su MA, et al.: Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet 1997;16:383-386.
86. 86. Gunshin H, Mackenzie B, Berger UV, et al.: Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 1997;388:482-488.
87. 87. Andrews NC, Fleming MD, Levy JE: Molecular insights into mechanisms of iron transport. Curr Opin Hematol 1999;6:61-64.
88. 88. Nelson N: Metal ion transporters and homeostasis. EMBO J 1999;18:4361-4371.
89. 89. Fleming MD, Romano MA, Su MA, Garrick LM, Garrick MD, Andrews NC: Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. Proc Natl Acad Sci USA 1998;95: 1148-1153.
90. 90. Fleming RE, Migas MC, Zhou X, et al.: Mechanism of increased iron absorption in murine model of hereditary hemochromatosis: increased duodenal expression of the iron transporter DMT1. Proc Natl Acad Sci USA 1999; 96:3143-3148.
91. 91. Han O, Fleet JC, Wood RJ: Reciprocal regulation of HFE and Nramp2 gene expression by iron in human intestinal cells. J Nutr 1999;129:98-104.
92. 92. Vidal SM, Malo D, Vogan K, Skamene E, Gros P: Natural resistance to infection with intracellular parasites: isolation of a candidate for Beg. Cell 1993;73:469-485.
93. 93. Supek F, Supekova L, Nelson H, Nelson N: A yeast manganese transporter related to the macrophage protein involved in conferring resistance to mycobacteria. Proc Natl Acad Sci USA 1996;93:5105-5110.
94. 94. Supek F, Supekova L, Nelson H, Nelson N: Function of metal-ion homeostasis in the cell division cycle, mitochondrial protein processing, sensitivity to mycobacterial infection and brain function. J Exp Biol 1997;200:321-330.
95. 95. Franco A, Paroli M, Testa U, et al.: Transfeirin receptor mediates uptake and presentation of hepatitis B envelope antigen by T lymphocytes. J Exp Med 1992;175:1195-1205.
96. 96. Gagliardi MC, Nisini R, Benvenuto R, De Petrillo G, Michel ML, Bamaba V: Soluble transferrin mediates targeting of hepatitis B envelope antigen to transferrin receptor and its presentation by activated T cells. Eur J Immunol 1994;24:1372-1376.
97. 97. Neckers LM, Cossman J: Transferrin receptor induction in mitogen-stimulated human T lymphocytes is required for DNA synthesis and cell division and is regulated by interleukin 2. Proc Natl Acad Sci USA 1983;80:3494-3498.
98. 98. Cantrell DA, Smith KA: The interleukin-2 T-cell system: a new cell growth model. Science 1984;224:1312-1316.
99. 99. Depper JM, Leonard WJ, Drogula C, Kronke M, Waldmann TA, Greene WC: Interleukin 2 (IL-2) augments transcription of the IL-2 receptor gene. Proc Natl Acad Sci USA 1985;82:4230-4234.
100. 100. Neckers LM: Regulation of transferrin receptor expression and control of cell growth. Pathobiology 1991;59:11-18.
101. 101. Golding S, Young SP: Iron requirements of human lymphocytes: relative contributions of intra-and extra-cellular iron. Scand J Immunol 1995;41:229-236.
102. + T cells. Clin Exp Immunol 1993;92:174-179.
103. 103. Seiser C, Teixeira S, Kuhn LC: InterIeukin-2-dependent transcriptional and post-transcriptional regulation of transferrin receptor mRNA. J Biol Chem 1993;268: 13,074-13,080.
104. 104. Kudoh S, Stanley J, Edinger MG, et al.: T lymphocytes infiltrating renal cell carcinoma have a reduced expression of transferrin receptor. Int J Cancer 1994;58:369-375.
105. 105. Woodward JE, Bayer AL, Chavin KD, Boleza KA, Baliga P: Anti-transferrin receptor monoclonal antibody: A novel immunosuppressant. Transplantation 1998; 65:6-9.
106. 106. Bayer AL, Baliga P, Woodward JE: Transferrin receptor in T cell activation and transplantation. J Leukocyte Biol 1998;64:19-24.
107. 107. Salmeron A, Borroto A, Fresno M, Crumpton MJ, Ley SC, Alarcon B: Transferrin receptor induces tyrosine phosphoryiation in T cells and is physically associated with the TCR ζ-chain. J. Immunol. 1995;154: 1675-1683.
108. 108. Jazwinska EC, Cullen LM, Busfield F, et al.: Hemochromatosis and HLA-H. Nat Genet 1996;14:249-251.
109. 109. Jouanolle AM, Gandon G, Jezequel P, et al.: Hemochromatosis and HLA-H. Nat Genet 1996;14:251-252.
110. 110. Porto G, Vicente C, Teixeira MA, et al.: Relative impact of HLA phenotype and CD4-CD8 ratios on the clinical expression of hemochromatosis. Hepatology 1997;25:397-402.
111. 111. de Sousa M, Porto G: The immunological system in hemochromatosis. J Hepatol 1998;28:1-7.
112. 112. Arosa FA, da Silva AJ, Godinho IM, et al.: Decreased CD8-p561ck activity in peripheral blood T-lymphocytes from patients with hereditary hemochromatosis. Scand J Immunol 1994;39:426-432.
113. + lymphocytes and iron overload. Eur J Haematol 1994;52:283-290.
114. - T cells. Clin Exp Immunol 1997;107:548-554.
115. 115. Santos M, Schilham M, Clevers H, et al.: Dysregulation of iron metabolism in mice with severe combined immunodeficiency. Abstract, European Iron Club, Gargano del Garda, Italy 1994.
116. 116. Cabeda JM, Porto G, da Silva BM, Vicente C, Posnett DN, de Sousa M: Anomalies of the expression of T-cell-receptor variable genes in hemochromatosis: An MHC-class I linked genetic disease of iron overload. Abstract, European Iron Club, Gargano del Garda, Italy 1994.
117. 117. Hershberg R, Eghtesady P, Sydora B, et al.: Expression of the thymus leukemia antigen in mouse intestinal epithelium. Proc Natl Acad Sci USA 1990;87:9727-9731.
118. 118. Wu M, van Kaer L, Itohara S, Tonegawa S: Highly restricted expression of the thymus leukemia antigens on intestinal epithelial cells. J Exp Med 1991;174:213-218.
119. 119. Groh V, Rhinehart R, Secrist H, Bauer S, Grabstein KH, Spies T: Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB. Proc Natl Acad Sci USA 1999;96:6879-6884.
120. 120. Groh V, Steinle A, Bauer S, Spies T: Recognition of stress-induced MHC molecules by intestinal epithelial γδ T cells. Science 1998; 279:1737-1740.
121. 121. Young D, Lathigra R, Hendrix R, Sweetser D, Young RA: Stress proteins are immune targets in leprosy and tuberculosis. Proc Natl Acad Sci USA 1988;85:4267-4270.
122. 122. Holoshitz J, Koning F, Coligan JE, De Bruyn J, Strober S: Isolation of CD4-CDS-mycobacteria-reactive T lymphocyte clones from rheumatoid arthritis synovial fluid. Nature 1989;339:226-229.
123. 123. Thompson SJ, Rook GA, Brealey RJ, Van der Zee R, Elson CJ: Auto-immune reactions to heat-shock proteins in pristane-induced arthritis. Eur J Immunol 1990;20: 2479-2484.
124. 124. Havran WL, Chien YH, Allison JP: Recognition of self antigens by skin-derived T cells with invariant γδ antigen receptors. Science 1991;252:1430-1432.
125. 125. Panja A, Blumberg RS, Balk SP, Mayer L: CD1d is involved in T cell-intestinal epithelial cell interactions. J Exp Med 1993;178: 1115-1119.
126. 126. Yio XY, Mayer L: Characterization of a 180-kDa intestinal epithelial cell membrane glycoprotein, gp 180. A candidate molecule mediating T cell-epithelial cell interactions. J Biol Chem 1997;272:12,786-12,792.
127. 127. Ten Elshof AE, Brittenham GM, Chorney KA, et al.: γδ intra-epithelial lymphocytes drive tumor necrosis factor-α responsiveness to intestinal iron challenge: Relevance to hemochromatosis. Immunol Rev 1999;167:223-232.
128. 128. Gordeuk VR, Ballou S, Lozanski G, Brittenham GM: Decreased concentrations of tumor necrosis factor-α in supernatants of monocytes from homozygotes for hereditary hemochromatosis. Blood 1992;79:1855-1860.
129. 129. Miller LL, Miller SC, Torti SV, Tsuji Y, Torti FM: Iron-independent induction of ferritin H chain by tumor necrosis factor. Proc Natl Acad Sci USA 1991;88:4946-4950.
130. 130. Rogers J, Lacroix L, Durmowitz G, Kasschau K, Andriotakis J, Bridges KR: The role of cytokines in the regulation of ferritin expression. Adv Exp Med Biol 1994; 356:127-132.
131. 131. Tran TN, Eubanks SK, Schaffer KJ, Zhou CY, Linder MC: Secretion of ferritin by rat hepatoma cells and its regulation by inflammatory cytokines and iron. Blood 1997;90:4979-4986.
132. 132. Yang Y, Salter-Cid L, Peterson PA: Hemochromatosis protein (HFE), in The Encyclopedia of Molecular Medicine. Creighton TE, ed. John Wiley & Sons, New York 2000 (in press).